Sinco Pharmaceuticals Holdings Limited

HK$0.12As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6833Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (13.12%)
Div yield 1.38%
ROE 4.36%
Medical Distribution
Beta (5Y) 1.23
PE TTM 7.083
TSR TTM (35.07%)
Mkt cap HK$246.0M
ROIC 8.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.14
15.40%
(36.02%)
Hold 1|0|2|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
—
—
—
—
20.67%
13.99%
18.69%
22.13%
Revenue¥M
30.65
31.42
30.95
30.36
13.16%
10.08%
2.77%
(2.53%)
Peers (US$31.38M)
Cap (US$)
PE
30.68M
—
Capital
TTM
5Y
10Y
Leveragex
1.014
1.132
0.877
EBIT/Intx
0.189
0.347
0.284
Own earn%
191.02
(113.14)
(95.82)
Sh yield%
23.98
21.93
22.10
Owners
Insiders/Inst%
8.01
35.03
Short interest%
4.64
SBC / revenue%
5.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
3